To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Parthenon readies sale of Trinity Life Sciences
The anticipated sale process comes fresh on the heels of GHO Capital’s recent $700m-plus bet for another life sciences strategy consulting business, ClearView Healthcare Partners.
